Catherine Vitosh
Family Medicine · Derby, KSNPI 1124181573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $653 and has fallen 80.0% since, to $130 in 2022.
Across 122 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$333
- Amgen$284
- Astellas Pharma US Inc$171
- Novo Nordisk$170
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- Amarin Pharma, Inc.$89
- plus $683 from 22 others
What the payments were for
- Food & beverage$1,825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $333 |
| Amgen | 16 | $284 |
| Astellas Pharma US Inc | 11 | $171 |
| Novo Nordisk | 14 | $170 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Amarin Pharma, Inc. | 5 | $89 |
| Sanofi-aventis U.S. LLC | 5 | $83 |
| Lilly USA, LLC | 6 | $76 |
| Novartis | 4 | $62 |
| Boehringer Ingelheim | 3 | $50 |
| Johnson & Johnson | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 3 | $40 |
| Merck | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $38 |
| Shire North American Group Inc | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Vivus LLC | 1 | $19 |
| Bayer | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Pfizer | 1 | $11 |
How this compares
$1,825 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Derby
- Glen PattonDerby$11K
- Bradley HarrisonManhattan$314K
- Mila MeansWichita$241K
- Scott AveryJunction City$195K
- Kent KiracofeManhattan$189K
- Terry McGeeneyLeawood$147K
- Cole GillenwaterWichita$62K
- David StricklandLawrence$53K
- Kyle PlatzManhattan$51K
- Eric AspinwallKansas City$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.